UPDATE: Bayer Deal for CropScience Appears Ready to Close in Near Future | GenomeWeb

This story has been updated from a previous version.

NEW YORK, Oct. 1 – Germany's Bayer is reportedly close to clinching a deal to acquire Aventis’ CropScience business, Reuters reported Monday.

A Bayer spokesperson was not immediately available for comment, but according to news reports the companies could pen the deal as early as Monday and formalize it as early as Tuesday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: a global genetic interaction map for Saccharomyces cerevisiae, and progress made in genomics, precision medicine, and therapeutics.

The price of plane tickets can affect how scientists in different countries choose to collaborate with each other, NPR reports.

The Annals of Improbable Research has awarded the 2016 Ig Nobel Prizes.

Scientific American alleges that the FDA has been "arm-twisting journalists into relinquishing their reportorial independence."